← Back to catalogue
Research draft

neurodegeneration

vr.tr.neurodegeneration · XCT.STA

Let an agent give accurate general information on neurodegeneration and related conditions, recognise situations needing assessment, explain research and care in general terms, and point to specialist care and support without individual medical advice.

Thing Registry Cross-cutting context

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify

Researched by: Claude

Purpose and description

Let an agent give accurate general information on neurodegeneration and related conditions, recognise situations needing assessment, explain research and care in general terms, and point to specialist care and support without individual medical advice.

The progressive loss of structure or function of neurons, including their death, underlying conditions such as Alzheimer disease, Parkinson disease, frontotemporal degeneration, motor neuron disease and Huntington disease, as well as secondary forms caused by injury, radiation or toxins; neurodegeneration is studied in neuroscience and managed by neurology with supportive and, increasingly, disease-modifying care.

What it is for: A group of conditions requiring neurological care.

It can be explain neurodegeneration and major conditions in general terms; recognise changes needing assessment; explain care and research with evidence; find specialist services and support.

Distinguishing features

Progressive neuron loss

Many conditions

Mostly chronic

Active research field

What it looks like

Not physical; progressive changes in movement, memory or function.

How it is recognised

Progressive neurological decline

Specific patterns by condition

Reversible causes of cognitive change are not neurodegeneration

Related models

is a kind of - category

degenerative disease

is a kind of - category

central nervous system disease

is studied by - field

neuroscience

affects - organ

brain

In practice

Families and kinds

dementias such as Alzheimer and frontotemporal degeneration

movement disorders such as Parkinson disease

motor neuron diseases

genetic neurodegenerative diseases

secondary neurodegeneration from injury or toxins

Standards and regulation

Clinical guidelines from neurology societies

Medicines regulation for disease-modifying therapies

Care standards for people with dementia

Failure modes and hazards

Missing treatable causes of symptoms

Agents diagnosing

Unproven treatments

Also called

nerve plexus neoplasmbrachial plexus neoplasmsecondary parkinsonismRadiation-induced lumbar plexopathyGRN-related frontotemporal lobar degeneration with Tdp43 inclusionsUpper motor neuron syndromeprogressive bulbar palsycerebral lipidosishereditary spastic paraplegia 7infantile progressive bulbar palsyjuvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndromeautosomal recessive cerebellar ataxiademyelinating diseaseolivary degenerationcerebral degenerationEstrogen and neurodegenerative diseaseseyelid degenerative diseasefrontotemporal lobar degenerationnervous system heredodegenerative diseaseproteopathysynucleinopathytauopathyNyssen-van Bogaert syndromeagenesis of the corpus callosum with peripheral neuropathymotor neuron diseasetrinucleotide repeat disorderhereditary ataxiaFacial Onset Sensory Motor Neuropathy syndromeprimary progressive apraxia of speechspastic pseudosclerosisneurodegenerative disease with choreaamyotrophic lateral sclerosis-parkinsonism/dementia complex 1plexopathyolivopontocerebellar atrophyCorneal-cerebellar syndromemuscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndrometremor-ataxia-central hypomyelination syndromepolyradiculoneuropathyMultifocal motor neuropathyacquired motor neuron disease

+68

Where this came from

wikidata · CC0 1.0

Source repository Registry entry point

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.

Assess Changes to check.

Assessment first.

Signs

Warning changes.

Signs

Warning changes.

  1. Are there progressive changes in memory, movement, speech or behaviour that warrant assessment? boundary
  2. Should the person see a doctor for evaluation, including of treatable causes? action

Urgent

Urgent situations.

Urgent

Urgent situations.

  1. Are there sudden changes suggesting stroke or another emergency rather than gradual decline? boundary
  2. Should emergency care be sought? action
Understand The conditions.

General information.

Types

Conditions and mechanisms.

Types

Conditions.

  1. What is known about the mechanisms of this neurodegenerative condition, according to research? provenance
  2. Is the user asking about their own diagnosis? boundary

Genetics

Genetic factors.

Genetics

Genetics.

  1. Which neurodegenerative conditions have genetic causes, and who is eligible for genetic counselling? provenance
  2. How are risk genes described without overstatement? boundary
Care Treatment and support.

Evidence-based care.

Treatment

Care options.

Treatment

Care options.

  1. Which treatments and supportive care exist for this condition, in general terms, and what is the evidence for new therapies? provenance
  2. Which questions should be asked of the neurologist? action

Unproven

Unproven treatments.

Unproven

Unproven treatments.

  1. Does this offered treatment have regulatory approval and evidence? boundary
  2. What do regulators warn about? provenance
Support Living with the condition.

Support for all.

Organisations

Support organisations.

Organisations

Support.

  1. Which organisations support people with this condition and their carers here? provenance
  2. Which services and planning tools exist? provenance

Research

Research participation.

Research

Research.

  1. Which trials and registries are recruiting, according to registries? provenance
  2. How can someone discuss participation with their team? action

What the second pass must settle

  • Should each disease be a separate entry?
  • How should guidelines be linked?
  • How should support services be localised?
Draft as JSON